Clinical Trial Update: Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)

View source ↗

Summary

This completed trial assessed how pegylated interferon and ribavirin affect virologic and immunologic parameters in patients with hepatitis C, including those c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: UMC Utrecht | Conditions: Hepatitis C, HIV Infections | Status: COMPLETED